Literature DB >> 19262069

A comprehensive analysis of immunohistochemical studies in intrahepatic cholangiocarcinoma using the survival tree model.

Tomohiro Iguchi1, Natsumi Yamashita, Shinichi Aishima, Yousuke Kuroda, Takahiro Terashi, Keishi Sugimachi, Ken-ichi Taguchi, Akinobu Taketomi, Yoshihiko Maehara, Masazumi Tsuneyoshi.   

Abstract

OBJECTIVE: Various immunohistochemical studies have been performed regarding intrahepatic cholangiocarcinoma (ICC), including the cell cycle-related proteins (p27, cyclin D1, 14-3-3sigma, p53, cyclin B1 and Ki-67), the proto-oncogenes (c-erbB-2 and c-Met), the extracellular matrix proteins (tenascin and laminin) and others (beta-catenin, epidermal growth factor receptor, osteopontin, aquaporin 1, MUC5AC and fascin). Nevertheless, none of these have been proven to be a predictive power of the prognosis with high specificity and sensitivity for ICC.
METHODS: Sixty-one patients with ICC were selected and ICC specimens were immunohistochemically stained with the above 16 markers, as previously reported.
RESULTS: The immunoreactivity of osteopontin, tenascin and Ki-67 divided the patients with ICC into 4 subgroups by the survival tree model. There was a significant relationship between the location of the tumor, TNM classification, histological differentiation, tumor size, lymphatic permeation, perineural invasion, lymph node metastasis, intrahepatic metastasis and viral infection among the 4 subgroups. In addition, there was a significant difference in survival among the 4 subgroups.
CONCLUSION: In this study, the subgrouping by the survival tree model might be helpful for predicting the patients' prognosis in ICC. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19262069     DOI: 10.1159/000207506

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  9 in total

Review 1.  The role of actin bundling proteins in the assembly of filopodia in epithelial cells.

Authors:  Seema Khurana; Sudeep P George
Journal:  Cell Adh Migr       Date:  2011 Sep-Oct       Impact factor: 3.405

2.  Serum p53 antibody as a potential tumor marker in extrahepatic cholangiocarcinoma.

Authors:  Rei Okada; Hideaki Shimada; Yuichiro Otsuka; Masaru Tsuchiya; Jun Ishii; Toshio Katagiri; Tetsuya Maeda; Yoshihisa Kubota; Tetsuo Nemoto; Hironori Kaneko
Journal:  Surg Today       Date:  2017-05-15       Impact factor: 2.549

3.  Osteopontin promoter polymorphisms at locus -443 are associated with metastasis and poor prognosis of human intrahepatic cholangiocarcinoma in Chinese population.

Authors:  Xiang-Qian Zhao; Huan-Xian Ma; Mao-Sheng Su; Lei He
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 4.  Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.

Authors:  Isaiah G Schauer; Anil K Sood; Samuel Mok; Jinsong Liu
Journal:  Neoplasia       Date:  2011-05       Impact factor: 5.715

5.  Cholangiocarcinoma pathogenesis: Role of the tumor microenvironment.

Authors:  Dinorah Leyva-Illades; Matthew McMillin; Matthew Quinn; Sharon Demorrow
Journal:  Transl Gastrointest Cancer       Date:  2012

6.  Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases.

Authors:  Marut Laohaviroj; Yaovalux Chamgramol; Chawalit Pairojkul; Jason Mulvenna; Banchob Sripa
Journal:  Asian Pac J Cancer Prev       Date:  2016

7.  Circulating osteopontin per tumor volume as a prognostic biomarker for resectable intrahepatic cholangiocarcinoma.

Authors:  Kai-Qian Zhou; Wei-Feng Liu; Liu-Xiao Yang; Yun-Fan Sun; Jie Hu; Fei-Yu Chen; Cheng Zhou; Xiang-Yu Zhang; Yuan-Fei Peng; Lei Yu; Jian Zhou; Jia Fan; Zheng Wang
Journal:  Hepatobiliary Surg Nutr       Date:  2019-12       Impact factor: 7.293

8.  Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI-PEG20 treatment in CCA cell lines.

Authors:  Somphon Roeksomtawin; Panida Navasumrit; Somchamai Waraprasit; Varabhorn Parnlob; Thaniya Sricharunrat; Vajarabhongsa Bhudhisawasdi; Niramol Savaraj; Mathuros Ruchirawat
Journal:  Oncol Lett       Date:  2018-05-24       Impact factor: 2.967

9.  Tenascin-W Is a Novel Stromal Marker in Biliary Tract Cancers.

Authors:  Ismaïl Hendaoui; Ahlem Lahmar; Luca Campo; Sihem Mebarki; Sandrine Bichet; Daniel Hess; Martin Degen; Nidhameddine Kchir; Leila Charrada-Ben Farhat; Rania Hefaiedh; Christian Ruiz; Luigi M Terracciano; Richard P Tucker; Lotfi Hendaoui; Ruth Chiquet-Ehrismann
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.